Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Lifecore Biomedical, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 76 | 1 | 87 | +12 |
| Shares | 24.8M | 28.8K | 24.5M | −258.1K (−1.0%) |
| Value | $202.4M | $214.3K | $190.0M | −$12.1M (−6.0%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Lifecore Biomedical, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LPL Financial LLC | 145,900 | $1.03M | 0.00% |
| Millennium Management LLC | 100,813 | $709.7K | 0.00% |
| Boston Partners | 34,175 | $240.6K | 0.00% |
| Citadel Advisors LLC | 30,523 | $214.9K | 0.00% |
| Nuveen, LLC | 28,837 | $203.0K | 0.00% |
| XTX Topco Ltd | 20,599 | $145.0K | 0.01% |
| SummitTX Capital, L.P. | 16,200 | $114.0K | 0.01% |
| HRT Financial LP | 13,029 | $91.0K | 0.00% |
| Catalyst Funds Management Pty Ltd | 11,100 | $78.1K | 0.02% |
| Price T Rowe Associates Inc | 10,799 | $77.0K | 0.00% |
| Hurley Capital, LLC | 5,000 | $35.2K | 0.03% |
| Group One Trading, L.P. | 4,300 | $30.3K | 0.00% |
| Clear Street Markets LLC | 3,690 | $26.0K | 0.02% |
| Macquarie Group Ltd | 904 | $6.36K | 0.00% |
| SJS Investment Consulting Inc. | 174 | $1.23K | 0.00% |
| True Wealth Design, LLC | 6 | $43 | 0.00% |
Sold out (4)
Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Invesco Ltd. | 555,607 | $4.13M |
| Boothbay Fund Management, LLC | 87,142 | $647.5K |
| Rangeley Capital, LLC | 43,700 | $324.7K |
| Diametric Capital, LP | 43,146 | $320.6K |
Not filed for Q1 2025 yet (1)
Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 28,837 | $214.3K |